More than 2 weeks of treatment with cefepime administered by intravenous (IV) push significantly increases the risk of cefepime-induced neutropenia.

Total Bill: $18,735.93, including two $722.50 fees for a nurse to “push” drugs into her IV, a process that takes seconds. Anthem’s negotiated charges were $6,999 for the total treatment.

- TMB-302 study results demonstrate that there was no difference in pharmacokinetics between IV Push and IV Infusion - - No serious adverse events observed – - sBLA filing planned for Q4 2021 ...

The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated to include a 90-second intravenous (IV) push loading dose.. Trogarzo, a CD4-directed post-attachment HIV-1 inhibitor ...

A majority of nurses — 83 percent — reported that they further dilute certain IV push medications for adult patients prior to administration, according to a survey conducted by the Institute ...

Reduces maintenance dose from a 15-minute IV infusion to a 30-second, undiluted IV push every two weeksSafety profile of Trogarzo® IV push similar to that of IV infusionNew method of ...

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...